載入...
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
Androgen receptor (AR) signaling is a critical pathway for prostate cancer cells, and androgen-deprivation therapy (ADT) remains the principal treatment for patients with locally advanced and metastatic disease. However, over time, most tumors become resistant to ADT. The view of castration-resistan...
Na minha lista:
| 發表在: | Oncogene |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333106/ https://ncbi.nlm.nih.gov/pubmed/24837363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.115 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|